Question: What is cryosurgery?
Cryosurgery or cryoablation involves freezing targeted areas
of the body in order to kill cancer cells. This technology
has been found to be very effective in treating localized prostate
cancer as well as select kidney cancers. It has been FDA
approved to treat these cancers.
Question: Why Dr. Hendricks?
Dr. Hendricks has more experience utilizing cryosurgery than
any other urologist in the area. He is a surgical proctor,
traveling to other hospitals to train other urologists how to utilize
this exciting new technology. He also has regular training
workshops in Napa, where other urologists go to watch him do cases
and learn the techniques.
Cryosurgery can be done in a minimally invasive fashion with minimal, if any, pain after the procedure and quick recovery. Dr. Hendricks has been performing prostatic cryoablation since 1994 and kidney cryoablation for four years and has had excellent outcomes. He currently does more kidney cryoablation than any other urologist in California, including those in universities.
Prostate cancer affects 1 out of 6 men in their lifetime. There
are many options to treat prostate cancer. If the cancer
is localized to the prostate, cryoablation of the prostate is an
excellent treatment choice. It can be used as a first-line
treatment for localized prostate cancer or to treat recurrent
localized prostate cancer after radiation treatment.
Dr. Hendricks had early experience using prostate cryoablation
as salvage therapy for radiation failures as a urological
resident at Columbia University with Dr.
Aaron Katz in the mid to late 1990's. While in training he
directly participated in dozens of the initial cases utilizing
this technology. Patients treated during that time are all
part of Dr. Katz's recent publication on his ten year experience
using prostate cryoablation as salvage therapy for radiation
cancer is diagnosed in about 30,000 people each year in the US,
and 12,000 die each year of the disease. Most kidney cancers
are found incidentally on imaging studies done for other reasons. The
majority of these cancers are found early, meaning before the cancer
has spread outside of the kidney.
There is now an increasing amount of evidence that targeted
cryoablation of select renal cancers is equally efficacious to standard
therapies for this condition. For tumors that are less than 5 cm in
size, the success rate in multiple trials is 95 percent, with most
of the failures being larger tumors. The success rate for
tumors 4 cm or less has been 100 percent in many centers, including
those patients treated by Dr. Hendricks.
Contact us at (707)224-7944 if you would like a consultation on these state-of-the-art, successful treament options in beautiful Napa!
Copyright 2006 Napa Valley Urology Associates